Age Related Macular Degeneration

AMD has two forms - wet and dry. Below is an overview of wet and dry AMD

What is the Macula?

The macula is the center part of the retina that we look straight ahead with. The eye works like a camera. The retina is like the film in the back of a camera. The center of the retina is called the macula. When you look at someone's face or read a book, you are using your macula. That is where your fine vision is. The rest of the retina is for the side or peripheral vision. You cannot see well with your peripheral vision, but you can get around and function with your peripheral vision. Macular degeneration can cause central vision loss, but never causes loss of peripheral vision (side vision).

What is Dry Macular Degeneration?

Dry AMD occurs when drusen develop in the macula (see photo). Most people with dry AMD have normal or near normal vision. Only about 10 percent develop advanced dry AMD. Advanced dry AMD occurs when the retina thins out so much that the vision declines. We call the thin spots geographic atrophy. We recommend vitamins for patients with dry AMD and fish oil. Patient with dry AMD should follow their vision and amsler grid every day and report to their physician if their is a change in vision in either eye or a change on the amsler grid. It is very important to check each eye separately.

Read more

What is Wet Macular Degeneration?

Wet AMD occurs when blood vessels start to grow in the macula. These blood vessels can also grow with scar tissue and blood (see photo). Untreated, most people with wet AMD lose their central vision. With treatment, the disease progression can usually be stopped and often reversed. Promt treatment leads to the best results, so if you have a sudden change in vision that could be a sign of wet AMD, you should see your physician urgently.

Read more

Macular Degeneration NEWS

Below are current articles from a Google News Feed on Macular Degeneration


Drug tests slow macular degeneration - Arkansas Democrat-Gazette
Arkansas Online
WASHINGTON -- An experimental drug is showing promise against an untreatable eye disease that blinds older adults -- and intriguingly, it seems to work in ...

and more »

Bel Marra Health

Dietary and lifestyle recommendations for patients at risk of macular ...
Science Daily
Age-related macular degeneration (AMD) is a major cause of severe visual impairment in older populations and is characterized by progressive destruction of ...
How do eye doctors recommend lifestyle changes to their AMD ...Bel Marra Health

all 2 news articles »

Macular degeneration
Journal Advocate
The diagnosis of macular degeneration is frightening to most people — how are they going to take care of themselves and remain independent? Age-related macular degeneration affects 8 million Americans. Macular degeneration is a painless degeneration ...


CBS News

Experimental drug offers hope to seniors with vision-robbing disease
CBS News
Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are different forms but more than 5 million people worldwide, and a million in the U.S., have an advanced type ...
Experimental Drug Able To Slow Macular Degeneration For Seniors With Genetic FlawCalifornia Healthline

all 8 news articles »

Dietary and lifestyle recommendations for patients at risk of macular degeneration
EurekAlert (press release)
Optometrists were more likely to recommend nutritional supplements in AMD and provided significantly more advice about diet than ophthalmologists for both patients at risk for AMD and those with established disease. Ophthalmologists, however, were more ...

and more »

The Japan Times

New therapy shows promise in slowing progression of macular degeneration
The Japan Times
WASHINGTON – An experimental treatment may significantly slow the progression of the blindness-causing disorder macular degeneration, in what would mark the first therapy of its kind, research showed Wednesday. There are currently no available ...

and more »

Macular degeneration: Drusen as promising biomarkers for progression of the disease
Science Daily
Age-Related Macular Degeneration (AMD) is a common disease of the centre of the retina, primarily affecting those aged over 50. The first signs of the disease are so-called drusen, which occur under the retina in the form of round, yellow deposits ...


Arizona Daily Star

Tucson Tech: New radiation treatment for eye disease advances
Arizona Daily Star
In a minimally invasive procedure that could be performed on an outpatient basis, the applicator is inserted through a small incision in the eyelid and worked around to the back of the eye, where it is rested outside the macula, an area in the center ...


Age-Related Macular Degeneration Affects More Than Just Your Vision
PR Newswire (press release)
CORONA, Calif., June 21, 2017 /PRNewswire/ -- The diagnosis of low vision due to age, such as macular degeneration, often comes with more consequences than just the inability to see. A new study by the National Eye Institute (NEI) reports that patients ...

and more »

Cincinnati.com

Select foods to discourage macular degeneration
Cincinnati.com
Age-related macular degeneration is the leading cause of vision loss and blindness in folks over the age of 50 in the Western world, affecting about 25 to 30 million people. The number of older adults is increasing in the United States as baby boomers ...


Ithaca Journal

Macular degeneration poses vision risk to seniors
Ithaca Journal
Macular degeneration is a leading cause of vision loss among people age 50 and older. It causes damage to the macula, a small spot near the center of the retina and the part of the eye needed for sharp, central vision. Because it is most common among ...


New Hope for Macular Degeneration Cure
DTN The Progressive Farmer (registration) (blog)
Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are different forms but more than 5 million people worldwide, and a million in the U.S., have an advanced type ...

and more »

Japan Today

New therapy for macular degeneration shows promise: study ...
Japan Today
An experimental treatment may significantly slow the progression of the blindness-causing disorder macular degeneration, in what would mark the first therapy ...

and more »

Southeast Missourian

Local healthcare professionals give their best advice for optical disease prevention
Southeast Missourian
"The main things we screen for that people don't know they have is the need for glasses, but you can also catch diabetes, hypertension, glaucoma, cataracts and macular degeneration early before a patient may be aware that they have those things," says ...


Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026
MarketWatch
Much opportunity remains in this growing AMD and Other Retinal Diseases market [https://www.visiongain.com/Report/1589/Macular-Degeneration-(AMD)-and-Other-Retinal-Diseases-World-Drug-Industry-and-Market-2016-2026 ] . See how to exploit the ...

and more »

Pittsburgh Post-Gazette

Drug shows promise against vision-robbing disease in seniors ...
Pittsburgh Post-Gazette
Initial research could lead to help in preventing age-related macular degeneration.
New Macular Degeneration therapy showing promiseTempo
An antibody provides new therapy for macular degenerationWest - Welfare Society Territory

all 6 news articles »

Treehugger

Chickens may help solve the mysteries of the human eye
Treehugger
The leading cause of vision loss among people aged 50 or older is macular degeneration, an incurable eye disease that affects over 10 million Americans. The disease is caused by the deterioration of the macula, the region of the retina in which the ...

and more »

Medical Xpress

Drusen as promising biomarkers for progression of macular degeneration
Medical Xpress
Age-Related Macular Degeneration (AMD) is a common disease of the centre of the retina, primarily affecting those aged over 50. The first signs of the disease are so-called drusen, which occur under the retina in the form of round, yellow deposits ...

and more »

Science Daily

Chickens may illuminate how humans developed sharp daylight vision
Science Daily
If the discoveries hold true in humans, the work might also one day provide clues about how to combat macular degeneration, the leading cause of vision loss among people age 50 and older. The macula is the part of the retina where the fovea is found.


Refinery29

What's The Difference Between An Ophthalmologist & Optometrist?
Refinery29
Getting contact lenses or prescription glasses online is as easy as ordering takeout these days. But, unlike the burrito you can summon to your door with minimal human interaction, you have to see an eye doctor IRL to get the prescription for your ...


KLAS-TV

Doctor's study says Vegas company makes supplement that fights Macular Degeneration
KLAS-TV
LAS VEGAS - The older people get, the harder it is to maintain sharp vision. Millions of Americans already suffer from symptoms of Macular Degeneration, a disease that results in total blindness for many people. However, a neutraceutical product made ...


The Intelligencer

Blanche Pilling
The Intelligencer
... Catholic Church, 321 Witmer Road, Horsham, PA 19044, where the viewing will be held from 10 to 11 a.m. Interment will be in Whitemarsh Memorial Park. In lieu of flowers, donations may be made to ASPCA or American Macular Degeneration Foundation.

and more »

WebWire (press release)

Nutrition Researcher Releases Health Guide about how to beat Macular Degeneration
WebWire (press release)
Paralegal and management systems analyst Alan N. McClain devoted years of research and study to his ground-breaking book How I Beat Macular Degeneration in the Early Stages and How You Can, Too! (CreateSpace Independent Publishing Platform, ...


FiercePharma

Novartis takes on Regeneron with AMD drug that needs fewer doses than Eylea
FiercePharma
Last year, U.S. sales of Regeneron's drug to treat age-related macular degeneration (AMD) came in at $3.3 billion—68% of the company's total revenues—so it's no wonder investors have been expressing some concerns about potential rivals moving through ...
Novartis Eye Drug Works With Fewer Injections Than RivalNew York Times
Novartis' RTH258 for wet AMD meets endpoints in phase 3 trialsHealio
Could Novartis' Drug Topple Regeneron's Blockbuster Eylea?Investor's Business Daily
BioPharma Dive -MedPage Today -Novartis
all 32 news articles »

SupportSight Seminar on Age-Related Macular Degeneration is offered
Burlington County Times
The Macula Vision Research Foundation will present a free seminar on age-related macular degeneration on June 20, from 6 to 8 p.m. in Delran. Learn about the latest research, prevention, treatments and low vision strategies. Check-in is at 5:15 p.m. at ...


In-depth Analysis of Global Age-related Macular Degeneration Market to grow at a CAGR of 7.37% during the period ...
Medgadget (blog)
While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD. Technavios analysts forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.


Novartis Cardiovascular Drug Positive, NSCLC Drug Approved
Nasdaq
The studies enrolled more than 1,800 patients with neovascular age-related macular degeneration (nAMD) in the trials. The primary and key secondary efficacy endpoints were non-inferiority of RTH258 to Regeneron Pharmaceuticals's REGN Eylea in mean ...

and more »

Just Jared

Returning from France, a blind World War II veteran lost his medals at a rest stop
Miami Herald
According to the Staffordshire Newsletter, Barlow, who fought at Sword Beach on D-Day in 1944, turned 96 on Sunday and lost his eyesight from macular degeneration and glaucoma. “It would make my birthday if I was able to have them back again,” Barlow ...
PLEASE HELP: Blind war veteran appeals for return of medals lost at an M6 service stationStoke Sentinel
Blind D-Day veteran Alfred Barlow's war medals lost at Staffordshire servicesStaff Newsletter
Actor Hugh Grant offers reward for blind veteran's lost medalsGlasgow Evening Times

all 23 news articles »

Genetic Literacy Project

Age-related macular degeneration may be treatable using viral injection gene therapy
Genetic Literacy Project
[R]esearchers from Johns Hopkins Medicine were looking for ways to treat a particular type of age-related macular degeneration (AMD) known as a wet AMD. It's a rare and more severe form of the disease [that] causes new blood vessels to grow under the ...


Santa Barbara Independent

The SB Questionnaire: Michael Lazarovits
Santa Barbara Independent
Having started at the Los Angeles chapter, he transferred to working in our city twenty-two years ago and has been Executive Director at the Braille Institute SB for 15 years. 75% to 80% of people who come to the Institute suffer from macular degeneration.

» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America